Keratinocyte Growth Factor: Not Yet Ready for Prime Time
- 15 April 2003
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (8), 1429-1430
- https://doi.org/10.1200/jco.2003.02.041
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal ProtectantJournal of Clinical Oncology, 2003
- Nonspecific Medication Side Effects and the Nocebo PhenomenonJAMA, 2002
- Interventions for treating oral candidiasis for patients with cancer receiving treatmentCochrane Database of Systematic Reviews, 2001
- Sucralfate in the Prevention of Treatment-Induced Diarrhea in Patients Receiving Pelvic Radiation Therapy: A North Central Cancer Treatment Group Phase III Double-Blind Placebo-Controlled TrialJournal of Clinical Oncology, 2000
- Preoperative irradiation affects functional results after surgery for rectal cancerDiseases of the Colon & Rectum, 1998
- Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancerBritish Journal of Surgery, 1997
- RTOG's first quality of life study—RTOG 90-20: A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- The Long-Term Effect of Adjuvant Postoperative Chemoradiotherapy for Rectal Carcinoma on Bowel FunctionAnnals of Surgery, 1994
- Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitisOral Oncology, 1994
- Effective Surgical Adjuvant Therapy for High-Risk Rectal CarcinomaNew England Journal of Medicine, 1991